Combined with the presence and absence of ADAM family members’ expression in gliomas and the prognostic analysis, ADAMDEC1 had a great advantage in the prevention and treatment of gliomas, especially with the development of gene-targeted drugs. This evidence concerns the gene ADAMDEC1 and glioma.